Testing effectiveness (Phase 2)Study completedNCT04422431
What this trial is testing
Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840
Who this might be right for
Wilson Disease
Alexion Pharmaceuticals, Inc. 31